TruTrace Technologies Inc. (TTT.CN)
| Previous Close | 0.0500 |
| Open | 0.0500 |
| Bid | 0.0500 x N/A |
| Ask | 0.0550 x N/A |
| Day's Range | 0.0500 - 0.0500 |
| 52 Week Range | 0.0350 - 0.2300 |
| Volume | 147,525 |
| Avg. Volume | 164,464 |
| Market Cap | 5.969M |
| Beta (5Y Monthly) | 4.24 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0160 |
| Earnings Date | Aug. 23, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Business Wire
TruTrace Technologies Partners with California-Based LeafWorks to Create a Blockchain-Secured Platform for Validation of Cannabis Supply Chains
TORONTO, July 29, 2021--TruTrace Technologies (CSE: TTT; OTCQB: TTTSF), a developer of a fully-integrated blockchain platform for the legal cannabis, food, and pharmaceutical industries, today announced that it has signed a letter of intent with LeafWorks Inc., a female-founded AgTech genomics company specializing in plant identification, research and development initially for the cannabis industry, to create a blockchain-secured platform for supply chain validation in order to meet growing stan
- CNW Group
Nauticol Energy and Enhance Energy partner to capture up to one million tonnes of CO2 annually from Blue Methanol production and distribution business
CALGARY, AB, March 23, 2021 /CNW/ - Nauticol and Enhance have entered into an agreement to work collaboratively for the capture and sequestration of up to one million tonnes of CO2 each year from Nauticol's planned Blue Methanol facility to be built near Grande Prairie, Alberta.Nauticol is building a world scale methanol production and distribution business to supply the unmet and rapidly growing global demand for low carbon methanol.
- Business Wire
TruTrace Technologies Joins Forces with Customer Engagement Expert PharmaCentra to Provide a Blockchain-Secured Ecosystem for Medical Cannabis
TruTrace Technologies (CSE: TTT; OTCQB: TTTSF), developer of a fully-integrated blockchain platform for the legal cannabis, food, and pharmaceutical industries, today announced that it has signed a letter of intent (LOI) with Georgia-based PharmaCentra LLC – through its subsidiary CannabisBPO -- to support a clinical trial ecosystem built on standardized protocols and testing of cannabis products for use in the medical industry.
